Global DNA Vaccines Competitive Landscape Professional Research Report 2024

Global DNA Vaccines Competitive Landscape Professional Research Report 2024



Research Summary

DNA vaccines are a type of vaccination approach that utilizes genetically engineered DNA molecules to trigger an immune response in the body against specific pathogens. Unlike traditional vaccines that contain weakened or inactivated viruses or proteins, DNA vaccines consist of genes encoding antigens—proteins present on the surface of pathogens. When these DNA molecules are introduced into the body through injection, the cells take up the DNA and start producing the antigenic proteins. This stimulates an immune response, including the production of antibodies and the activation of immune cells, providing immunity against the targeted pathogen. DNA vaccines offer advantages such as ease of design and production, rapid development, and the potential for targeting multiple antigens simultaneously. They have been studied for their potential in preventing various infectious diseases and have shown promise in preclinical and clinical trials.

According to DIResearch's in-depth investigation and research, the global DNA Vaccines market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of DNA Vaccines include Merck, GSK, Sanofi, Zoties, Elanco, Indian Immunologicals, Boehringer-Ingelheim, Plumbline Life Sciences etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of DNA Vaccines. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global DNA Vaccines market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the DNA Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of DNA Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of DNA Vaccines Include:

Merck

GSK

Sanofi

Zoties

Elanco

Indian Immunologicals

Boehringer-Ingelheim

Plumbline Life Sciences

DNA Vaccines Product Segment Include:

Recombinant Protein Vaccine

Gene-Based Vaccine

DNA Vaccines Product Application Include:

Human

Animal

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global DNA Vaccines Industry PESTEL Analysis

Chapter 3: Global DNA Vaccines Industry Porter’s Five Forces Analysis

Chapter 4: Global DNA Vaccines Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global DNA Vaccines Market Size and Forecast by Type and Application Analysis

Chapter 6: North America DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa DNA Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global DNA Vaccines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 DNA Vaccines Market Overview
1.1 Product Definition and Statistical Scope
1.2 DNA Vaccines Product by Type
1.2.1 Global DNA Vaccines Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 DNA Vaccines Product by Application
1.3.1 Global DNA Vaccines Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Human
1.3.3 Animal
1.4 Global DNA Vaccines Market Revenue and Sales Analysis
1.4.1 Global DNA Vaccines Market Size Analysis (2019-2030)
1.4.2 Global DNA Vaccines Market Sales Analysis (2019-2030)
1.4.3 Global DNA Vaccines Market Sales Price Trend Analysis (2019-2030)
1.5 DNA Vaccines Market Development Status and Trends
1.5.1 DNA Vaccines Industry Development Status Analysis
1.5.2 DNA Vaccines Industry Development Trends Analysis
2 DNA Vaccines Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 DNA Vaccines Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global DNA Vaccines Market Analysis by Regions
4.1 DNA Vaccines Overall Market: 2023 VS 2024 VS 2030
4.2 Global DNA Vaccines Revenue and Forecast Analysis (2019-2030)
4.2.1 Global DNA Vaccines Revenue and Market Share by Region (2019-2024)
4.2.2 Global DNA Vaccines Revenue Forecast by Region (2025-2030)
4.3 Global DNA Vaccines Sales and Forecast Analysis (2019-2030)
4.3.1 Global DNA Vaccines Sales and Market Share by Region (2019-2024)
4.3.2 Global DNA Vaccines Sales Forecast by Region (2025-2030)
4.4 Global DNA Vaccines Sales Price Trend Analysis (2019-2030)
5 Global DNA Vaccines Market Size by Type and Application
5.1 Global DNA Vaccines Market Size by Type
5.1.1 Global DNA Vaccines Revenue and Forecast Analysis by Type (2019-2030)
5.1.2 Global DNA Vaccines Sales and Forecast Analysis by Type (2019-2030)
5.2 Global DNA Vaccines Market Size by Application
5.2.1 Global DNA Vaccines Revenue and Forecast Analysis by Application (2019-2030)
5.2.2 Global DNA Vaccines Sales and Forecast Analysis by Application (2019-2030)
6 North America
6.1 North America DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America DNA Vaccines Market Size by Type
6.3.1 North America DNA Vaccines Sales by Type (2019-2030)
6.3.2 North America DNA Vaccines Revenue by Type (2019-2030)
6.4 North America DNA Vaccines Market Size by Application
6.4.1 North America DNA Vaccines Sales by Application (2019-2030)
6.4.2 North America DNA Vaccines Revenue by Application (2019-2030)
6.5 North America DNA Vaccines Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe DNA Vaccines Market Size by Type
7.3.1 Europe DNA Vaccines Sales by Type (2019-2030)
7.3.2 Europe DNA Vaccines Revenue by Type (2019-2030)
7.4 Europe DNA Vaccines Market Size by Application
7.4.1 Europe DNA Vaccines Sales by Application (2019-2030)
7.4.2  Europe DNA Vaccines Revenue by Application (2019-2030)
7.5 Europe DNA Vaccines Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China DNA Vaccines Market Size by Type
8.3.1 China DNA Vaccines Sales by Type (2019-2030)
8.3.2 China DNA Vaccines Revenue by Type (2019-2030)
8.4 China DNA Vaccines Market Size by Application
8.4.1 China DNA Vaccines Sales by Application (2019-2030)
8.4.2 China DNA Vaccines Revenue by Application (2019-2030)
9 APAC (excl. China)
9.1 APAC (excl. China) DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) DNA Vaccines Market Size by Type
9.3.1 APAC (excl. China) DNA Vaccines Sales by Type (2019-2030)
9.3.2 APAC (excl. China) DNA Vaccines Revenue by Type (2019-2030)
9.4 APAC (excl. China) DNA Vaccines Market Size by Application
9.4.1 APAC (excl. China) DNA Vaccines Sales by Application (2019-2030)
9.4.2 APAC (excl. China) DNA Vaccines Revenue by Application (2019-2030)
9.5 APAC (excl. China) DNA Vaccines Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America DNA Vaccines Market Size by Type
10.3.1 Latin America DNA Vaccines Sales by Type (2019-2030)
10.3.2 Latin America DNA Vaccines Revenue by Type (2019-2030)
10.4 Latin America DNA Vaccines Market Size by Application
10.4.1 Latin America DNA Vaccines Sales by Application (2019-2030)
10.4.2 Latin America DNA Vaccines Revenue by Application (2019-2030)
10.5 Latin America DNA Vaccines Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa DNA Vaccines Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa DNA Vaccines Market Size by Type
11.3.1 Middle East & Africa DNA Vaccines Sales by Type (2019-2030)
11.3.2 Middle East & Africa DNA Vaccines Revenue by Type (2019-2030)
11.4 Middle East & Africa DNA Vaccines Market Size by Application
11.4.1 Middle East & Africa DNA Vaccines Sales by Application (2019-2030)
11.4.2 Middle East & Africa DNA Vaccines Revenue by Application (2019-2030)
11.5 Middle East & Africa DNA Vaccines Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global DNA Vaccines Market Sales, Revenue and Price by Key Manufacturers (2020-2024)
12.1.1 Global DNA Vaccines Market Sales by Key Manufacturers (2020-2024)
12.1.2 Global DNA Vaccines Market Revenue by Key Manufacturers (2020-2024)
12.1.3 Global DNA Vaccines Average Sales Price by Manufacturers (2020-2024)
12.2 DNA Vaccines Competitive Landscape Analysis and Market Dynamic
12.2.1 DNA Vaccines Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Merck
13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Merck DNA Vaccines Product Portfolio
13.1.3 Merck DNA Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.2 GSK
13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 GSK DNA Vaccines Product Portfolio
13.2.3 GSK DNA Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.3 Sanofi
13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Sanofi DNA Vaccines Product Portfolio
13.3.3 Sanofi DNA Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.4 Zoties
13.4.1 Zoties Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Zoties DNA Vaccines Product Portfolio
13.4.3 Zoties DNA Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.5 Elanco
13.5.1 Elanco Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Elanco DNA Vaccines Product Portfolio
13.5.3 Elanco DNA Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.6 Indian Immunologicals
13.6.1 Indian Immunologicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Indian Immunologicals DNA Vaccines Product Portfolio
13.6.3 Indian Immunologicals DNA Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.7 Boehringer-Ingelheim
13.7.1 Boehringer-Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Boehringer-Ingelheim DNA Vaccines Product Portfolio
13.7.3 Boehringer-Ingelheim DNA Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.8 Plumbline Life Sciences
13.8.1 Plumbline Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Plumbline Life Sciences DNA Vaccines Product Portfolio
13.8.3 Plumbline Life Sciences DNA Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 DNA Vaccines Industry Chain Analysis
14.2 DNA Vaccines Industry Upstream Supply Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 DNA Vaccines Typical Downstream Customers
14.4 DNA Vaccines Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings